Eric Woglom joined Ropes & Gray as a partner in 2005 when it merged with Fish & Neave, the IP boutique where he had been a partner from 1976 to 2004. He retired on June 30, 2008, although he continues to do some client work.
Concentrating in chemical and biochemical cases, Eric has acted for the world’s leaders in technology: ExxonMobil, General Electric, Milliken, Univation, Inco, Rhodia, Massachusetts Institute of Technology, BASF, Schering-Plough, Biogen, Squibb, Knoll Pharmaceuticals, AlliedSignal and Ebara. Eric’s engagements have included: Schering-Plough v. Interferon Sciences (alpha interferon); Schering-Plough v. Sterling Winthrop (interleukin-4); BioZone v. Knoll Pharmaceuticals (capsaicin); Squibb v. Medi+Physics (medical diagnostics); Biogen v. Roche (alpha interferon); ExxonMobil v. Dow (polyethylene); Mobil v. Exxon (metallocene catalysts); ExxonMobil v. Chevron Phillips (polymerization); General Electric v. Sun Oil (phenols); SWS v. General Electric (silicones); Benchmark v. Rhodia (guar-based fracturing fluids); Dow v. Univation (polyethylene); Milliken v. Mohawk (polyurethane-based floor coverings); Witco v. BASF (rigid polyurethane foams); Sheller-Globe v. Milsco [BASF] (integral skin polyurethane foams); Valent v. BASF (herbicides); Eli Lilly v. BASF (herbicides); FilmTec v. AlliedSignal (reverse osmosis membranes); Semitool v. Ebara (seed-layer repair in semiconductor chip manufacturing).
- The Best Lawyers in America
- Euromoney's Guide to the World’s Leading Patent Law Experts
- Who’s Who in America
- Who’s Who in the Law
- New York Super Lawyers